Peritonitis Affects the Relationship Between Low-Density Lipoprotein Cholesterol and Cardiovascular Events in

Hongjian Ye1, Haishan Wu1, Yuan Peng1

  • 1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Key Laboratory of Nephrology, National Health Commission and Guangdong Province, Guangzhou, China.

Insights

In peritoneal dialysis (PD), lower low-density lipoprotein cholesterol (LDL-C) increases peritonitis risk. The impact of LDL-C on cardiovascular events and mortality differs based on peritonitis presence.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • The interplay between low-density lipoprotein cholesterol (LDL-C), peritonitis, and cardiovascular (CV) disease in peritoneal dialysis (PD) patients remains unclear.
  • Understanding these relationships is crucial for managing CV risk in this vulnerable population.

Purpose of the Study:

  • To investigate the associations between baseline LDL-C levels, peritonitis incidence, and major CV events in a large cohort of incident PD patients.
  • To explore how peritonitis modifies the relationship between LDL-C and CV outcomes.

Main Methods:

  • Retrospective cohort study of 1294 incident PD patients.
  • Primary outcome: first major CV event (myocardial infarction, CV death, stroke, arterial revascularization).
  • Secondary outcomes: peritonitis, CV mortality, all-cause mortality. Analyzed associations using regression and competing risk models.

Main Results:

  • Lower baseline LDL-C quartiles were independently linked to a higher risk of peritonitis.
  • No significant association between baseline LDL-C and CV events in the overall cohort.
  • Among peritonitis-free patients, increased LDL-C correlated with higher CV risk; conversely, among patients with peritonitis, increased LDL-C correlated with lower CV risk.
  • Peritonitis significantly moderated the LDL-C-CV event relationship and influenced LDL-C-mortality associations.

Conclusions:

  • Lower baseline LDL-C is associated with increased peritonitis risk in PD patients.
  • The effect of LDL-C on cardiovascular events and mortality is significantly modified by the presence or absence of peritonitis.
Abstract

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
418
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
552
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
300
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
1.9K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
495
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
260